DP009 | THE PROGNOSTIC ROLE OF DEL 9P21.3 (CDKN2A) IN PATIENTS WITH MANTLE CELL LYMPHOMA. RESULTS FROM THE FIL_MANTLE-FIRST BIO STUDY.

Mantle Cell Lymphoma (MCL) is an aggressive malignancy with variable clinical behaviour, largely reflecting its molecular heterogeneity. The genomic landscape of MCL encompasses gene mutations with strong prognostic implications (i.e., TP53, NOTCH1/2, KMT2D, etc), and secondary genetic events such...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	M.E. Carazzolo, F.M. Quaglia, A. Aparo, A. Parisi, R. Moia, F. Piazza, A. Re, M.C. Tisi, M. Ciceri, P. Bulian, A. Castellino, V.R. Zilioli, P.M. Stefani, A. Fabbri, E. Lucchini, A. Arcari, L. Lorenzi, B. Famengo, M. Ponzoni, A. Ferrari, S. Ragaini, J. Olivieri, M.T. Scupoli, V. Salaorni, S. Gambino, M. Galasso, C. Visco
Format:	Artigo
Sprog:	Inglês
Udgivet:	Ferrata Storti Foundation 2025-09-01
Serier:	Haematologica
Online adgang:	https://haematologica.org/article/view/12773
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!